CBD for Epilepsy: FDA Approves Prescribed CBD as an Epilepsy Medication, but there is a catch ...

Epidiolex adds another tool indicated for DRAVET and LGS ... but wait, CBD must still be rescheduled by the DEA. 

Will CBD be completely rescheduled? Call your legislator to ensure CBD a relatively safe and non-addictive substance is rescheduled. - JR

FDA Green Lights Marijuana-Based Pharmaceutical Drug

June 25, 20185:33 PM ET
 Allison Aubrey - 2015 square

ALLISON AUBREY

FULL Story HERE

The U.S. Food and Drug Administration has approved a marijuana-derived drug for the treatment of two rare and serious forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, that begin in childhood but can persist in adulthood.

The drug is made from purified cannabidiol, or CBD, a compound found in the cannabis plant. The drug will be marketed under the brand name Epidiolex.

CBD has medicinal effects, but it does not cause the mind-altering high that comes from THC, the primary psychoactive component of marijuana.

The FDA says this is the first drug approved in the U.S. that contains a purified substance derived from marijuana. The agency has previously approved drugs made from synthetic versions of THC and other marijuana constituents.

Dr. Rotenberg prescribes CBD for refractory epilepsy
under the CURT program
approved by the  State of Texas

"This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies," said FDA Commissioner Scott Gottlieb during a call with reporters about the approval.

Anxiety Relief Without The High? New Studies On CBD, A Cannabis Extract
SHOTS - HEALTH NEWS
Anxiety Relief Without The High? New Studies On CBD, A Cannabis Extract
Several states have legalized CBD oil specifically for the treatment of intractable epilepsy or seizure disorders. And, as NPR has reported, CBD supplements are available widely online and in dispensaries in the form of oils or tinctures. CBD oil has gained popularity with consumers as a remedy for a variety of other ailments. However, the legal status of these products is uncertain, as is their quality. They're not regulated the way pharmaceutical drugs are, so the consistency and dose can vary widely.

Having an FDA-approved, pharmaceutical-grade CBD drug will open up a new treatment option for epilepsy patients by delivering a high-quality, consistent dose